Biogen Exercises Option to Increase Ownership in Samsung Bioepis
June 28, 2018 16:06 ET
|
Biogen Inc.
Biogen will pay Samsung BioLogics approximately $700 million to increase its ownership in Samsung Bioepis to approximately 49.9%Transaction expected to close in the second half of 2018 CAMBRIDGE,...